Medical Journal Finds Possible Link Between GLP-1 Drugs, Blindness
BOSTON — A recent study published in the JAMA Ophthalmology found a potential link between semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), and an increased risk of a significant...To view the full article, register now.
Already a subscriber? Click here to view full article